An Exploratory Pilot Study with Plasma Protein Signatures Associated with Response of Patients with Depression to Antidepressant Treatment for 10 Weeks

Major depressive disorder (MDD) is a leading cause of global disability with a chronic and recurrent course. Recognition of biological markers that could predict and monitor response to drug treatment could personalize clinical decision-making, minimize unnecessary drug exposure, and achieve better...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eun Young, Ahn, Hee-Sung, Lee, Min Young, Yu, Jiyoung, Yeom, Jeonghun, Jeong, Hwangkyo, Min, Hophil, Lee, Hyun Jeong, Kim, Kyunggon, Ahn, Yong Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692261/
https://www.ncbi.nlm.nih.gov/pubmed/33126421
http://dx.doi.org/10.3390/biomedicines8110455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692261/
https://www.ncbi.nlm.nih.gov/pubmed/33126421
http://dx.doi.org/10.3390/biomedicines8110455

Ejemplares similares